Cargando…
The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues
We recently reported that SF2312 ((1,5-dihydroxy-2-oxopyrrolidin-3-yl)phosphonic acid), a phosphonate antibiotic with a previously unknown mode of action, is a potent inhibitor of the glycolytic enzyme, Enolase. SF2312 can only be synthesized as a racemic-diastereomeric mixture. However, co-crystal...
Autores principales: | Pisaneschi, Federica, Lin, Yu-Hsi, Leonard, Paul G., Satani, Nikunj, Yan, Victoria C., Hammoudi, Naima, Raghavan, Sudhir, Link, Todd M., K. Georgiou, Dimitra, Czako, Barbara, Muller, Florian L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651268/ https://www.ncbi.nlm.nih.gov/pubmed/31324042 http://dx.doi.org/10.3390/molecules24132510 |
Ejemplares similares
-
SF2312 is a natural phosphonate inhibitor of Enolase
por: Leonard, Paul G., et al.
Publicado: (2016) -
ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase
por: Satani, Nikunj, et al.
Publicado: (2016) -
Prodrugs of
a 1-Hydroxy-2-oxopiperidin-3-yl
Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers
por: Yan, Victoria C., et al.
Publicado: (2022) -
Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate
por: Krucinska, Jolanta, et al.
Publicado: (2019) -
An Enolase Inhibitor for the Targeted Treatment of ENO1-Deleted Cancers
por: Lin, Yu-Hsi, et al.
Publicado: (2020)